191 related articles for article (PubMed ID: 12045065)
1. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
Esmaeli B; Hortobagyi GN; Esteva FJ; Booser D; Ahmadi MA; Rivera E; Arbuckle R; Delpassand E; Guerra L; Valero V
Ophthalmology; 2002 Jun; 109(6):1188-91. PubMed ID: 12045065
[TBL] [Abstract][Full Text] [Related]
2. Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Esmaeli B; Hortobagyi G; Esteva F; Valero V; Ahmadi MA; Booser D; Ibrahim N; Delpassand E; Arbuckle R
Ann Oncol; 2002 Feb; 13(2):218-21. PubMed ID: 11885997
[TBL] [Abstract][Full Text] [Related]
3. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.
Ahmadi MA; Esmaeli B
Arch Ophthalmol; 2001 Dec; 119(12):1802-4. PubMed ID: 11735790
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.
Esmaeli B; Amin S; Valero V; Adinin R; Arbuckle R; Banay R; Do KA; Rivera E
J Clin Oncol; 2006 Aug; 24(22):3619-22. PubMed ID: 16877729
[TBL] [Abstract][Full Text] [Related]
6. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Esmaeli B; Valero V; Ahmadi MA; Booser D
Ophthalmology; 2001 May; 108(5):994-5. PubMed ID: 11320034
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.
Esmaeli B; Burnstine MA; Ahmadi MA; Prieto VG
Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):305-8. PubMed ID: 12878879
[TBL] [Abstract][Full Text] [Related]
8. Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.
Tsalic M; Gilboa M; Visel B; Miller B; Haim N
Med Oncol; 2006; 23(1):57-61. PubMed ID: 16645230
[TBL] [Abstract][Full Text] [Related]
9. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
Esmaeli B; Golio D; Lubecki L; Ajani J
Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
Tu AH; Chang EL
Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel-associated epiphora.
Kintzel PE; Michaud LB; Lange MK
Pharmacotherapy; 2006 Jun; 26(6):853-67. PubMed ID: 16716138
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel secretion in tears: association with lacrimal drainage obstruction.
Esmaeli B; Ahmadi MA; Rivera E; Valero V; Hutto T; Jackson DM; Newman RA
Arch Ophthalmol; 2002 Sep; 120(9):1180-2. PubMed ID: 12215091
[TBL] [Abstract][Full Text] [Related]
13. Management of excessive tearing as a side effect of docetaxel.
Esmaeli B
Clin Breast Cancer; 2005 Feb; 5(6):455-7. PubMed ID: 15748466
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction.
Mansur C; Pfeiffer ML; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2017; 33(1):9-12. PubMed ID: 27429222
[TBL] [Abstract][Full Text] [Related]
15. Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere).
Skolnick CA; Doughman DJ
Eye Contact Lens; 2003 Apr; 29(2):134-5. PubMed ID: 12695719
[TBL] [Abstract][Full Text] [Related]
16. Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel.
Esmaeli B; Hortobagyi GN
Oncologist; 2001; 6(6):551-2. PubMed ID: 11743218
[No Abstract] [Full Text] [Related]
17. Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.
Esteva FJ; Valero V; Booser D; Guerra LT; Murray JL; Pusztai L; Cristofanilli M; Arun B; Esmaeli B; Fritsche HA; Sneige N; Smith TL; Hortobagyi GN
J Clin Oncol; 2002 Apr; 20(7):1800-8. PubMed ID: 11919237
[TBL] [Abstract][Full Text] [Related]
18. The treatment of punctal and canalicular stenosis in patients on systemic 5-FU.
Fezza JP; Wesley RE; Klippenstein KA
Ophthalmic Surg Lasers; 1999 Feb; 30(2):105-8. PubMed ID: 10037204
[TBL] [Abstract][Full Text] [Related]
19. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
[TBL] [Abstract][Full Text] [Related]
20. Balloon canaliculoplasty for acquired canalicular stenosis.
Zoumalan CI; Maher EA; Lelli GJ; Lisman RD
Ophthalmic Plast Reconstr Surg; 2010; 26(6):459-61. PubMed ID: 20871460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
